Published Date: 02 Mar 2023
A link between depression and changes in various immune systems in the blood has been discovered by researchers from the Department of Integrative Epidemiology at MRC, University of Bristol. The results of this research...
Read Full NewsTelemedicine use is not associated with a substantial increase in mental health treatment among patients in rural, low-access, or distant communities, a new study shows.
A new analysis explores whether accelerating RT delivery with 6 fractions vs 5 fractions per week improves outcomes in patients with locally advanced HNSCC receiving concurrent chemotherapy.
Researchers have created nanoparticles that can remove disease-driving proteins while also delivering a chemotherapeutic or immunotherapeutic payload to cancer cells.
A population-based cohort study finds that an increased use of adjuvant systemic therapy can improve survival in patients with metachronous and synchronous bilateral breast cancer.
1.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
2.
Active Surveillance Lawsuits; More Eligibility for Studies; Biosimilars Make News.
3.
According to a study, there is now a 94 percent survival rate for children with acute lymphatic leukemia.
4.
Additional imaging techniques can detect early stage cancers missed by mammograms in women with dense breasts
5.
Urinary tract cancer prediction models with high sensitivity and specificity
1.
Navigating the Complexities of Esophageal Cancer Staging
2.
Omitting Axillary Dissection in Node-Positive Breast Cancer: Insights from the SENOMAC Trial
3.
Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine
4.
Breaking Barriers in Cancer Treatment: The Role of Innovative Oncology Drugs
5.
Understanding Bone Metastases: How Long Can Someone Live When Cancer Spreads To The Bones?
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
2.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
3.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
5.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation